Financials Electromedical Technologies, Inc.

Equities

EMED

US28540Q1004

Advanced Medical Equipment & Technology

Delayed OTC Markets 10:01:02 2024-04-29 am EDT 5-day change 1st Jan Change
0.0005 USD +8.70% Intraday chart for Electromedical Technologies, Inc. 0.00% -28.57%

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 36.48 8.436 5.888 1.283
Enterprise Value (EV) 1 38.95 9.542 7.077 2.891
P/E ratio -19.8 x -1.73 x -0.28 x -0.25 x
Yield - - - -
Capitalization / Revenue 44 x 11.4 x 6.49 x 1.12 x
EV / Revenue 46.9 x 12.9 x 7.8 x 2.51 x
EV / EBITDA -23.7 x -3.03 x -1.87 x -1.83 x
EV / FCF 172,331,030,973 x 10,260,796 x 13,412,959 x 4,279,061 x
FCF Yield 0% 0% 0% 0%
Price to Book -14.5 x -4.87 x -5.42 x -0.49 x
Nbr of stocks (in thousands) 17,797 28,118 88,472 191,531
Reference price 2 2.050 0.3000 0.0666 0.006700
Announcement Date 5/8/20 3/30/21 3/31/22 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.8577 0.6754 0.8297 0.738 0.9074 1.15
EBITDA 1 -0.4341 -0.2584 -1.644 -3.145 -3.778 -1.582
EBIT 1 -0.4567 -0.2807 -1.669 -3.167 -3.8 -1.604
Operating Margin -53.25% -41.56% -201.1% -429.11% -418.83% -139.46%
Earnings before Tax (EBT) 1 -0.5104 -1.95 -1.744 -3.872 -8.48 -3.468
Net income 1 -0.5104 -1.95 -1.744 -3.872 -8.48 -3.468
Net margin -59.51% -288.79% -210.23% -524.65% -934.59% -301.65%
EPS 2 -0.0340 -0.1283 -0.1038 -0.1736 -0.2403 -0.0268
Free Cash Flow - -0.5842 0.000226 0.9299 0.5276 0.6757
FCF margin - -86.5% 0.03% 126.02% 58.15% 58.76%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/12/19 11/12/19 5/8/20 3/30/21 3/31/22 3/31/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.99 2.6 2.46 1.11 1.19 1.61
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -2.284 x -10.05 x -1.499 x -0.3518 x -0.3147 x -1.017 x
Free Cash Flow - -0.58 0 0.93 0.53 0.68
ROE (net income / shareholders' equity) - 134% 82.2% 221% 831% 236%
ROA (Net income/ Total Assets) - -16.3% -111% -171% -169% -72.7%
Assets 1 - 11.99 1.574 2.269 5.033 4.768
Book Value Per Share 2 -0.0600 -0.1300 -0.1400 -0.0600 -0.0100 -0.0100
Cash Flow per Share 2 0 - - 0.0100 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 11/12/19 11/12/19 5/8/20 3/30/21 3/31/22 3/31/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. EMED Stock
  4. Financials Electromedical Technologies, Inc.